Login / Signup

Compliance with multidisciplinary team meeting management recommendations.

Amali SamarasingheArlene ChanDiana HastrichRichard MartinAlbert GanFarah AbdulazizMargaret LathamYvonne ZissiadisMandy TaylorPeter Willsher
Published in: Asia-Pacific journal of clinical oncology (2019)
A total of 2614 MDT management recommendations were made for 925 patients. Overall, 92% were compliant with all recommendations given. Clinical trial recruitment was successful in 84.1%. The reasons given for treatment noncompliance were fear of toxicity, choosing an alternative treatment, and treatment inconvenience. In a subset of 337 EBC patients, there was a significantly higher rate of contralateral breast cancer, distant recurrence, and breast cancer-specific death, P = .0016, in those who were noncompliant. Our study demonstrates a high rate of MDT treatment recommendation compliance and clinical trial recruitment. In a subgroup of EBC patients, noncompliance was associated with significantly worse outcomes. Attention to educating patients to minimize their fear of treatment toxicity and ensuring their understanding of evidence-based treatment may lead to lower rates of noncompliance.
Keyphrases